Download as PDF Robert Michael Bernstein MD MBA FAAD FISHRS Address: 110 East 55th Street, 11th Fl., New York, NY 10022 Phone: 212.826.2400 Fax: 212.826.6200 Email: rbernstein@bernsteinmedical.com Website: www.bernsteinmedical.com EDUCATION 1969-1973 Tulane University, New Orleans, Louisiana Bachelor of Science in Psychology conferred on May 13, 1973 Honors: Tulane Scholar, Cum Laude, President of Psi Chi […]
Hair loss affects millions of men and women, both young and old. It can decrease self-esteem and confidence, and limit the ability to enjoy life to the fullest. Persons balding at a young age may feel deprived of an essential element of their youth. This feeling is created and affirmed by cultures all over the […]
Non-profit Organizations National Alopecia Areata Foundation (NAAF) supports research to find a cure or acceptable treatment for alopecia areata, supports those with the disease, and educates the public about alopecia areata. Founded in 1981, NAAF is widely regarded as the largest, most influential and most representative foundation associated with alopecia areata. Cicatricial Alopecia Research Foundation […]
110 E 55th St. (11th Floor) New York, NY 10022 HAIR LOSS SOLUTIONS HAIR LOSS SOLUTIONS Let the team at Bernstein Medical Find the best option for you. Before & After Photos Photo Journal FAQ FUE vs FUT Answers Video Physician Consult Hair transplantation is an out-patient surgical procedure in which hair is transplanted from […]
Latisse, the brand name for the drug bimatoprost, is commonly used to promote eyelash growth in women who want their eyelashes to be longer, thicker, and darker, typically for cosmetic reasons. In a publication on ClinicalTrials.gov, Allergan, the pharmaceutical company that produces Latisse, has announced a new study on the safety and efficacy of a new formulation of bimatoprost for use as a topical hair loss treatment for general baldness.
"Good Morning America" interviewed Dr. Bernstein in their two-part series on hair transplant surgery. Below is an excerpt from the interview: Charles Gibson: Are there good candidates and bad candidates for this? Dr. Bernstein: Yes. And actually people that wear hairpieces are sometimes tricky because their baseline is a full head of hair, so one of the important things that we had to discuss in the first consult was what his expectations were and whether he realized that a transplant wouldn't give him the fullness of a hairpiece, but of course, it would look much more natural. Watch the full interview.
The hair follicle growth cycle consists of three phases: a growth phase (“anagen”), a transitional phase (“catagen”), and a resting phase (“telogen”). In susceptible hair follicles, the hormone dihydrotestosterone (DHT) can, over time, cause the growth phase of the hair cycle to become progressively shorter. As a result, the individual hairs produced by these follicles decrease in size (diameter and length) until they eventually disappear. This process is called “miniaturization.” It is the main mechanism in androgenetic alopecia (genetic balding). Miniaturization: The Mechanismin Genetic BaldingNormal scalp hair grows in follicular units made up of one to four terminal (full thickness) hairs. The terminal hairs in any single DHT-susceptible follicular unit might be in varying stages of miniaturization, and thus be of varying diameters. When enough terminal hairs are in a state of miniaturization, there appears to be a visible thinning of the hair in the affected areas. As more hairs in each follicular unit become miniaturized, the process may lead to complete baldness in that area of the scalp.
Q: Over the past three months, my hair seems to be thinning more on one side. Is it common in male pattern hair loss for it to be more on one side? I had a lot of stress about three months ago and have heard that this could be the cause. Is this possible? Should I use Rogaine to treat it? -- B.R., Landover, MD A: Regardless of the cause, hair loss is usually not perfectly symmetric. This applies to male pattern hair loss as well. In your case, it is important to distinguish between telogen effluvium (shedding that can be due to stress) and hereditary or common baldness. The three month interval from the stressful period to the onset of hair loss is characteristic telogen effluvium, but you may have androgenetic alopecia as an underlying problem. The two conditions are differentiated by identifying club hairs in telogen effluvium and miniaturized hair in androgenetic alopecia. In addition, a hair pull will be positive in telogen effluvium (when a clump of hair is grasped with the fingers, more than five hairs pull out of the scalp at one time) and will be negative in common baldness. The hair loss diagnosis can…
Hair loss affects millions of men and women worldwide, often leading to concerns about appearance and self-confidence. While many temporary treatments exist, hair transplants offer a long-term solution that restores natural hair growth. If you’ve ever wondered, how do hair transplants work? you’ll find that the procedure is based on moving healthy follicles from […]
Hair Transplants in Young Patients Surgical hair restoration is generally not advised for patients younger than 25 with androgenetic alopecia (male pattern baldness) for these reasons: In a young person, one cannot tell if the donor area will be stable over time. If the donor area is not stable, then there may not be enough permanent hair to transplant. The earlier one’s hair loss begins, the more extensive it will likely become. With extensive hair loss, the demand for hair may exceed the donor supply and, therefore, the coverage that would be possible with a hair transplant would not be enough to satisfy a young person (whose goal is generally a full head of hair and a low hairline).